Application 089331
- Type
- ANDA
- Sponsor
- QUAD PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | HYDROXYPROGESTERONE CAPROATE | HYDROXYPROGESTERONE CAPROATE | Injectable; Injection | 250MG/ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydroxyprogesterone Caproate | HYDROXYPROGESTERONE CAPROATE | Eugia US LLC | 687bcf42-f437-42c7-8909-a91f621f55df | 2026-06-12 | Warnings, Adverse reactions | Hydroxyprogesterone Caproate HYDROXYPROGESTERONE CAPROATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.